Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2009
11/05/2009WO2009046879A3 Use of the combination of npy and nociceptin as a therapeutic agent
11/05/2009WO2009046876A3 Use of a peptide as a therapeutic agent
11/05/2009WO2009043526A3 Use of gip ( 6-30) alone or in combination with hgh as a therapeutic agent
11/05/2009WO2009040051A9 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent
11/05/2009WO2009040005A9 Use of the peptide rfmwmr as a therapeutic agent
11/05/2009WO2009033819A3 Use of glicentin-related polypeptide and apelin- 13 in combination as therapeutic agents, eg for treating aids
11/05/2009WO2009033797A3 Use of apelin-17 and peptide yy as therapeutic agents, eg for treating hbv infection
11/05/2009WO2009033785A3 Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hiv infection
11/05/2009WO2009033784A3 Use of apelin-13 (qrprlshkgpmpf) and optionally aplha-casein (90-96) as a therapeutic agents in eg the treatment of hiv infection
11/05/2009WO2009033738A3 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent
11/05/2009WO2009033712A3 Use of melanotan ii as a therapeutic agent
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275651 Alcanoic Acid Amides Substituted by Saturated O-Heterocycles
11/05/2009US20090275648 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
11/05/2009US20090275627 Alpha2b and alpha2c agonists
11/05/2009US20090275623 Alpha-amino acid derivatives and medicaments containing the same as an active ingredient
11/05/2009US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009US20090275588 Novel sulfonamide compounds
11/05/2009US20090275581 Renin inhibitors
11/05/2009US20090275580 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
11/05/2009US20090275579 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
11/05/2009US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009US20090275571 Morpholinyl and pyrrolidinyl analogs
11/05/2009US20090275564 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/05/2009US20090275563 Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy
11/05/2009US20090275548 Compounds and methods for activated therapy
11/05/2009US20090275544 Method and kit for reducing the symptoms of peripheral vascular disease
11/05/2009US20090275542 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
11/05/2009US20090275541 Method for treating neurocognitive dysfunction
11/05/2009US20090275539 Nuclear Transcription Factors Regulators
11/05/2009US20090275537 Certain chemical entities, compositions, and methods
11/05/2009US20090275529 Method for improving cardiovascular risk profile of cox inhibitors
11/05/2009US20090275524 Novel hypocholesterolemic compounds
11/05/2009US20090275522 Novel Compounds
11/05/2009US20090275514 Use of calmodulin kinase ii inhibitors to treat or prevent heart muscle inflammation
11/05/2009US20090275512 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
11/05/2009US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009US20090275498 Novel peptides
11/05/2009US20090275133 Antisense modulation of c-reactive protein expression
11/05/2009US20090274776 Method for the Diagnosis and Treatment of Conditions Involving Aberrant Erythrocyte Potassium Levels
11/05/2009US20090274743 Medical devices having a bioresorbable coating layer with a pre-determined pattern for fragmentation
11/05/2009US20090274736 Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
11/05/2009US20090274709 Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks
11/05/2009US20090274706 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009US20090274689 For improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size in absence of removal of the arterial obstruction
11/05/2009US20090274680 Human Phospholipases
11/05/2009DE102008021329A1 Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium diisocitrate in hydrate or anhydrate form for preventing and treating high blood pressure and in human and animal medicine
11/05/2009DE102008020127A1 Kompartimentspezifische Pflanzenextraktkombination aus Ginkgo biloba- und Ginseng-Extrakt mit Tandemwirkung Compartment specific combination of ginkgo biloba plant extract and ginseng extract with tandem effect
11/05/2009CA2729053A1 Vinyl substituted fatty acids
11/05/2009CA2723276A1 Fgf-9 and its use relating to blood vessels
11/05/2009CA2723132A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
11/05/2009CA2723118A1 Polymerized cyclic nitroxide radical compound and use thereof
11/05/2009CA2722938A1 New peptidomimetic compounds
11/05/2009CA2722815A1 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration
11/05/2009CA2722772A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009CA2722137A1 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/05/2009CA2721560A1 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
11/05/2009CA2630510A1 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009EP1729823B1 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1480736B1 Microcapsules having high carotenoid content
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009CN101573354A Substituted isoquinolines and their use as Rho-kinase inhibitors
11/04/2009CN101573353A Substituted isoquinoline and isoquinolinone derivatives
11/04/2009CN101573131A Anti-connexin compounds and uses thereof
11/04/2009CN101570528A Glycyrrhizin derivatives and preparation and use thereof
11/04/2009CN101570510A Quinoline compound, pharmaceutical composition, preparation method and application thereof
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612225 Endothelin receptor antagonist, useful for treating various circulatory system diseases such as hypertension, ischemic disorders, cerebral circulatory disorders, renal disorders, circulatory insufficiency of various organs, asthma, stroke
11/03/2009US7612175 Having an SR structure and a collectin-like structure ; drug screening; , diabetic complications and Alzheimer's disease, hyper beta -lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo alpha -lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections
11/03/2009US7612174 Scavenger receptor
11/03/2009US7612164 Cardiac muscle function and manipulation
11/03/2009US7612114 Selective estrogen receptor modulator
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612078 Piperidinylamino-thieno[2,3-D] pyrimidine compounds
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009US7612058 Administering 1-(4-fluorophenyl)-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl)]-4(S)-[4-(phenylmethoxy)phenyl]-2-azetidinone; and peroxisome proliferator-activated receptor activator; obesity, antidiabetic agents
11/03/2009US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009CA2415476C Matrix controlled transdermal system for stabile derivatives of ace inhibitors
11/03/2009CA2404210C Pharmaceutical gel composition
11/03/2009CA2402222C Sustained release ranolazine formulations
11/03/2009CA2383220C Controlled release pellet formulation
11/03/2009CA2360767C Tricyclic benzodiazepines as vasopressin receptor antagonists
11/03/2009CA2324283C Pharmaceutical composition containing a statin and aspirin
11/03/2009CA2205379C Yeast-based delivery vehicles
11/03/2009CA2174338C Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
10/2009
10/29/2009WO2009132136A1 Carboxamide compounds for the treatment of metabolic disorders
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 1595